ADPD 2023: Alzheimer's Disease Therapeutics, Diagnostics & Mechanisms
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
Frontiers | Alzheimer's disease: a mini-review for the clinician
New Alzheimer's Biomarkers may Support Early Diagnosis
Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine
The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy | Nano Letters
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
JPM | Free Full-Text | Biomarkers for Alzheimer's Disease Early Diagnosis
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments | Cell Research
Biomolecules | Free Full-Text | Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease - eBioMedicine
Cells | Free Full-Text | Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
